Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 293

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 293
---
 ordinary shares of the Company effective upon the occurrence of a merger of the
Company with OceanTech. (refer to Note 14).

:

As of December 31, 2023, and 2022, there
are total of 31,716 options outstanding to purchase its ordinary shares, at an exercise price of $9.933. 16,716 options were granted to
Company’s service providers and 15,000 options were granted to Company’s director. The outstanding options were granted in prior
years and are fully vested with no future compensation expenses to be recognized. These options will expire in December 2029.

During the years ended December 31, 2023,
and 2022, the Company didn’t grant additional options and there were no exercise nor forfeiture of options.

As of December 31, 2023, and 2022, all
options are exercisable and have an exercise price of $9.933.

<div align='center'>F-42</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 11:- | SHAREHOLDERS’ DEFICIT (Cont.) |

As part of the receipt of a short-term
loan (refer to Note 5), the Company issued to the lenders 11,965 warrants which will be exercisable into ordinary shares at an exercise
price of NIS 0.01 per share for a period of 3 years from the issuance date. Upon completion of the Merger, the warrants will be exercisable
to 65,000 of common stocks of the surviving company.

The Company estimated the fair value of
the warrant using PWERM. The fair value of the warrants at the amount of $288 was recorded as an increase in Company’s additional
paid-in capital.

A summary of significant unobservable
inputs (Level 3 inputs) used in measuring the fair value of the warrants issued are as follows:

|               |     | August 15, 
 2023       |      |   |
|:--------------|:----|:-----------|-----:|:--|
| Discount rate |     |            | 30.0 | % |
| Term (years)  |     |            |    3 |   |
| Fair value    |     | $          |  288 |   |

| NOTE 12:- | SELECTED STATEMENTS OF COMPREHENSIVE